SCHEMBL2902991

SCHEMBL2902991

OB(O)c1ccc(-c2cc3ccc4ccccc4c3c3ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
MGLL Q99685 1/20 0.44
KDM4E B2RXH2 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 6/20 0.38
HPGD P15428 4/20 0.38
MAPT P10636 2/20 0.38
MPI P34949 1/20 0.38
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
ENPP2 Q13822 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
HSD17B10 Q99714 4/20 0.36
TSHR P16473 2/20 0.36
CYP1A2 P05177 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2478286 0.89 CA1 (0.54) CA1CA2MGLLKDM4EMEN1
SCHEMBL2469655 0.83 CA1 (0.50) CA1CA2MGLLKDM4EMEN1
SCHEMBL29634609 0.82 CA1 (0.46) CA1CA2MGLLALDH1A1HPGD
SCHEMBL3415294 0.80 CA2 (0.50) CA1CA2MGLLKDM4EMEN1
SCHEMBL12025762 0.78 GRM2 (0.43) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL12025740 0.78 CA1 (0.51) CA1CA2MGLLKDM4EMEN1
SCHEMBL12144584 0.78 CA1 (0.59) CA1CA2MGLLALDH1A1HPGD
SCHEMBL431998 0.78 CA1 (0.52) CA1CA2MGLLCA4CA6
SCHEMBL29384733 0.78 CA1 (0.52) CA1CA2MGLLCA4CA6
SCHEMBL30959842 0.78 CA1 (0.59) CA1CA2MGLLALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9614159-B2 Benzophenanthrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-9614159-B2 Benzophenanthrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-9614159-B2 Benzophenanthrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-20130285029-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-10-31 US disclosed
US-20130285029-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-10-31 US disclosed
US-20130285029-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-10-31 US disclosed
EP-2218706-B1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO (JP) 2013-08-21 EP disclosed
US-8507106-B2 Benzophenanthrene derivative and organic electroluminescent device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-13 US disclosed
US-8507106-B2 Benzophenanthrene derivative and organic electroluminescent device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-13 US disclosed
US-8507106-B2 Benzophenanthrene derivative and organic electroluminescent device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-13 US disclosed
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-23 US disclosed
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-23 US disclosed
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-23 US disclosed
EP-2218706-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2010-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME NRAS, RSU1, RAP1A CA1 2554/4885CA2 1797/4885MGLL 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.